Biogen Shares (Diluted) increased by 49366.7% to 148.4M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.2%, from 146.6M to 148.4M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 150.1M | 148.6M | 147.6M | 146.2M | 144.8M | 145.2M | 145.5M | 144.8M | 100K | 145.9M | 145.9M | 146.1M | 146.6M | 146.7M | 147.1M | 300K | 148.4M |
| QoQ Change | — | -1.0% | -0.7% | -0.9% | -1.0% | +0.3% | +0.2% | -0.5% | -99.9% | >999% | +0.0% | +0.1% | +0.3% | +0.1% | +0.3% | -99.8% | >999% |
| YoY Change | — | — | — | -2.6% | -2.6% | -1.6% | -0.5% | +0.0% | — | +0.5% | +0.3% | +0.9% | +0.5% | +0.5% | +0.7% | — | +1.2% |